Loading SMS Pharmaceuticals…
| ₹ Cr | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|
| Revenue | 207 | 238 | 210 | 242 | 196 |
| Operating profit | 31 | 30 | 34 | 38 | 28 |
| Operating margin | 15.0% | 12.5% | 16.0% | 15.8% | 14.4% |
| Net profit | 21 | 33 | 23 | 25 | 20 |
| Net margin | 10.1% | 13.7% | 11.2% | 10.4% | 10.5% |
| EPS (₹) | 2.23 | 3.58 | 2.59 | 2.84 | 2.31 |
Quarters are labelled by period end.
| ₹ Cr | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Revenue | 883 | 779 | 706 | 520 |
| Operating profit | 133 | 105 | 85 | 22 |
| Operating margin | 15.1% | 13.4% | 12.1% | 4.3% |
| Net profit | 102 | 69 | 50 | -7 |
| Net margin | 11.5% | 8.9% | 7.1% | -1.4% |
| EPS (₹) | 11.15 | 8.16 | 5.89 | -0.83 |
| ₹ Cr | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Total assets | 1,362 | 1,153 | 1,034 | 880 |
| Total liabilities | 577 | 513 | 498 | 419 |
| Shareholders’ equity | 786 | 640 | 536 | 461 |
| Total debt | 365 | 311 | 281 | 254 |
| Cash & equivalents | 46 | 41 | 36 | 7 |
| Debt / equity | 0.46 | 0.49 | 0.52 | 0.55 |
| ₹ Cr | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Operating cash flow | 59 | 82 | 50 | 22 |
| Capital expenditure | -131 | -123 | -52 | -30 |
| Free cash flow | -71 | -42 | -2 | -7 |
| ₹ Cr | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Return on equity | 13.0% | 10.8% | 9.3% | -1.5% |
| Return on assets | 7.5% | 6.0% | 4.8% | -0.8% |
| Net margin | 11.5% | 8.9% | 7.1% | -1.4% |
Source: Yahoo Finance. Figures in ₹ crore unless stated.
No analyst data available for SMSPHARMA. Finnhub coverage is limited for some India-listed stocks.